Clover Health is trading 4.12% up at $4.30, with no clear company-specific announcement dated August 26, 2026 explaining the move.
- Recent catalysts included strong second-quarter results and raised full-year guidance, reported August 5.
- An August 17 interim-CFO share sale was disclosed as an automatic tax-withholding transaction, not discretionary selling.